Study on the cerebral vision mechanism of electroacupuncture on the regulation function of myopia
- Conditions
- myopia
- Registration Number
- ITMCTR2100004899
- Lead Sponsor
- Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1.Pseudomyopia group:
(1) Aged from 6 to 16 years;
(2) Eyes meet the classification criteria of true and false myopia formulated by the Eye Branch of the Chinese Medical Association in 1985, that is, the patient's far vision is lower than normal, near vision is normal, and after the use of atropine paralysis of the ciliary muscle, myopia disappears, showing emmetropia or mild hyperopia is regarded as false myopia;
(3) Right hand;
(4) Informed consent, and voluntarily signed informed consent.
2.True myopia group:
(1) Ball mirror < -6.00D and prism < -1.50D;
(2) Refractive aberration <= 2.00D;
(3) Conforming to the standard of true myopia: if the refractive index of myopia did not decrease significantly after rapid pupil dilation with compound topiramate eye drops, or the decrease was less than 0.5D, it could be judged as true myopia;
(4) Corrected visual acuity: >= 1.0;
(5) Informed consent, and voluntarily signed informed consent.
1.Pseudomyopia group:
(1) Single or double-eye lens > 3.00D or cylindrical lens > 1.00D;
(2) Refractive aberration > 2.00D;
(3) Patients with binocular or monocular organic lesions that affect vision, such as corneal, iris, and fundus lesions;
(4) Long-term use of relevant treatment without termination;
(5) Patients with other serious systemic diseases, such as cardiovascular, cerebrovascular, liver, kidney, hematopoietic system and mental diseases;
(6) Participants in other clinical trials;
(7) According to the judgment of the researchers, other lesions that reduce the possibility of joining the group or complicate the joining the group are prone to loss of follow-up.
2.True myopia group:
(1) Patients with binocular or monocular organic lesions that affect vision, such as corneal, iris, lens and fundus lesions;
(2) Patients with severe systemic diseases, such as cardiovascular, cerebrovascular, liver, kidney, hematopoietic system and mental diseases; patients with allergic constitution or allergic to medical silicone; psychiatric patients;
(3) Participants in other clinical trials;
(4) Compliance with diagnosis, but objective conditions can not adhere to treatment, easy to lose follow-up.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method intraocular pressure;deoxyhemoglobin;ocular accommodation;diopter;oxyhemoglobin;total hemoglobin;vision;
- Secondary Outcome Measures
Name Time Method